Our top pick for
Beginners

Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Minerva Surgical Inc is a health information services business based in the US. Minerva Surgical shares (UTRS) are listed on the NASDAQ and all prices are listed in US Dollars. Minerva Surgical employs 157 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
Latest market close | $2.35 |
---|---|
52-week range | $1.61 - $12.00 |
50-day moving average | $2.61 |
200-day moving average | $4.90 |
Wall St. target price | $6.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.26 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.35 from 2022-07-01
1 week (2022-06-27) | -6.00% |
---|---|
1 month (2022-06-03) | -9.27% |
3 months (2022-04-05) | -47.19% |
6 months (2022-01-05) | -53.83% |
1 year (2021-07-01) | N/A |
---|---|
2 years (2020-07-01) | N/A |
3 years (2019-07-01) | N/A |
5 years (2017-07-01) | N/A |
Revenue TTM | $51.2 million |
---|---|
Gross profit TTM | $30.5 million |
Return on assets TTM | -22.49% |
Return on equity TTM | 0% |
Profit margin | -34.06% |
Book value | $1.21 |
Market capitalisation | $72.1 million |
TTM: trailing 12 months
We're not expecting Minerva Surgical to pay a dividend over the next 12 months.
You may also wish to consider:
Minerva Surgical, Inc. , a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California. .
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.